Loxo, Bayer get first FDA win with $400k rare cancer drug

A cutting-edge oncology drug developed by Loxo Oncology and Bayer has won approval in the U.S.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news